east-large-B.png
 

06.19.19

The Board Meeting series is designed to open minds and explore new trends that will translate into more effective governance and success throughout the life science industry.  The Board Meeting is an exclusive, invite-only, off the record meeting for life science CEOs and board members to discuss key issues and solve problems in an interactive and productive setting.

east-top-banner.jpg

SPONSORS

 
 
 
 
 
 
 
 

SPONSORSHIP OPPORTUNITIES

Sponsors gain access in an intimate and private setting with life science industry top leaders and decision makers.

For additional information, please contact Susan Grayson at susan@crushlifesicences.com or sponsor@crushlifesciences.com.


HILIGHTS from the BOARD MEETING 2018:

AGENDA - June 19, 2019

8:00 – 8:45 am                          
Registration and Networking Breakfast

8:45 – 9:00 am                          
Welcome and Opening Remarks

9:00 – 9:45 am
Creating the Lines of Communication
Ivana Magovcevic-Liebisch
, Chief Business Officer, Ipsen; Ankit Mahadevia, CEO, Spero Therapeutics; John Waid, Founder and CEO, C3 Corporate Culture Consulting
Moderator: Donna Higgins, President & CEO, The Higgins Group

9:45 - 10:30 am
More than Just Decor: The Board’s Role in Corporate and Business Strategy
Mark Leuchtenberger
, Interim President & CEO, Brooklyn ImmunoTherapeutics; Bob Linke, President and CEO, Embera NeuroTherapeutics; Paris Panayiotopoulos, Managing Director, Blackstone Life Sciences Group
Moderator: Rachael Bushey, Partner & Chair of Life Sciences, Pepper Hamilton, LLP

10:30 - 10:45 am
Networking Break

10:45 - 12:15 pm
Crisis Communications: An Interactive Experience Among Stakeholders
Dale Weiss
, Senior Vice President and Crisis Practice Leader, CommCore Consulting Group

12:15 - 1:15 pm
Networking Lunch

1:15 - 2:00 pm
Sounding Board: The Board’s Role in the IPO Process
Milind Deshpande
, CEO, Nayan Therapeutics;
Lori Henderson, General Counsel and Corporate Secretary, Moderna Therapeutics; Peter Verhaeghe, Chairman of the Board, Argenx
Moderator: John Rudy, Member, Securities & Capital Markets Practice, Mintz

2:00 - 2:45 pm
Patient Perception: Bringing the Patient into the Board Room
Robert Brown
, Founding Partner, Atlas Impact Partners; Rob Perez, Founder & Chairman, Life Science Cares; Mary Thistle, Chief of Staff, Bill & Melinda Gates Medical Research Initiative
Moderator:
Laurie Halloran, President, Halloran Consulting Group

2:45 - 3:30 pm
Pricing Paradigm: A New Driver of Corporate Strategy
Roger Longman
, CEO, Real Endpoints; Bruce Nash, Chief Physician Executive and Senior Vice President, Health and Medical Management, Blue Cross Blue Shield of Massachusetts
Moderator: Geoff Meyerson, Co-Founder & CEO, Locust Walk

3:30 - 3:45 pm
Networking Break

3:45 - 4:30 pm
Creating a Functioning Culture Within a Board
Dan Fisher,
Managing Partner and Consulting Psychologist, Contemporary Leadership Advisors; James Geraghty, Chairman of the Board, Idera Pharmaceuticals; Jeff Wager, Managing Director, Apeiron Partners
Moderator: Doug MacDougall, MacDougall Biomedical Communications

4:30 - 5:30 pm
Networking Cocktail Reception

 

crush-background.jpg

KEYNOTE SPEAKERS

 
portrait-jay.jpg
 

Jay W. Lorsch

Jay W. Lorsch is the Louis Kirstein Professor of Human Relations at the Harvard Business School. He is editor of The Future of Boards: Meeting the Governance Challenges of the Twenty-First Century (2012) He is the author of over a dozen books, the most recent of which are Back to the Drawing Board: Designing Boards for a Complex World (with Colin B. Carter, 2003), Aligning the Stars: How to Succeed When Professionals Drive Results (with Thomas J. Tierney, 2002), and Pawns or Potentates: The Reality of America's Corporate Boards (1989). Organization and Environment (with Paul R. Lawrence) won the Academy of Management's Best Management Book of the Year Award and the James A. Hamilton Book Award of the College of Hospital Administrators in 1969